SCHEMBL12828601

SCHEMBL12828601

O=C(NCc1cccnc1)C1=NOC(c2ccco2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
PKM P14618 2/20 0.50
ALOX15 P16050 1/20 0.50
NPC1 O15118 1/20 0.50
NPSR1 Q6W5P4 2/20 0.48
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
HSD17B10 Q99714 3/20 0.46
TSHR P16473 3/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2B P29275 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RECQL P46063 3/20 0.45
HPGD P15428 3/20 0.45
MAPK1 P28482 1/20 0.45
CYP17A1 P05093 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12828886 0.90 NAMPT (0.48) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL12828532 0.88 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4ENPC1
SCHEMBL12828280 0.79 RAB9A (0.55) ALDH1A1MEN1KMT2AKDM4EPKM
SCHEMBL650043 0.77 MLYCD (0.56) ALDH1A1HTTNPSR1SMN1; SMN2MAPT
SCHEMBL15319936 0.76 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL12828600 0.74 RAB9A (0.43) ALDH1A1KDM4ENPC1HSD17B10SMN1; SMN2
SCHEMBL12828521 0.74 TP53 (0.46) ALDH1A1NPC1SMN1; SMN2POLBMAPT
SCHEMBL12828599 0.74 RAB9A (0.45) ALDH1A1MEN1KMT2AKDM4EPKM
SCHEMBL12828281 0.74 KMT2A (0.40) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL12828524 0.73 NAMPT (0.41) ALDH1A1MEN1KMT2AKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 ALDH1A1 706/4885MEN1 4845/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.